2020 Annual Meeting | C102 - Peripheral Neuropathy 2: Approach to Sensory Neuropathies and Neuropathies Associated with Rheumatologic and Hematologic Disorders

Date Monday 04/27/20

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Michelle L. Mauermann, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to identify the causes of large and small fiber sensory neuropathies; perform appropriate testing for evaluation of sensory neuropathies; and determine a rational approach to treating sensory neuropathies. Participants should be able to recognize the clinical presentation of vasculitic neuropathies, establish diagnosis and work-up of vasculitic neuropathies and determine the evidence-based treatment for vasculitic neuropathies. Participants should become familiar with the relevance of monoclonal gammopathies in relationship to peripheral neuropathy; perform appropriate testing for plasmacytic disorders; and determine treatment approach to paraproteinemic disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:05 PM	Introduction	Introduction Michelle L. Mauermann, MD, FAAN
01:05 PM - 01:40 PM	Speaker	Sensory Neuropathies Sarah E. Berini, MD
01:40 PM - 02:15 PM	Speaker	Vasculitic Neuropathies Chafic Y. Karam, MD
02:15 PM - 02:50 PM	Speaker	Paraproteinemic Neuropathies Michelle L. Mauermann, MD, FAAN
02:50 PM - 03:00 PM	Q&A	Discussion/Questions and Answers

Faculty Disclosures
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.

��ɫ��

��ɫ��